Creating LASIK Flaps With the LenSx Femtosecond Laser

October 23, 2014 updated by: Alcon LenSx, Inc.

Prospective, Single-center Clinical Trial of Subjects Scheduled to Undergo LASIK Surgery Requiring an Initial Corneal Flap.

This will be a prospective, single-center clinical trial of up to 50 eyes of subjects scheduled to undergo LASIK surgery requiring an initial corneal flap. Subjects will be screened for eligibility.

Subjects will undergo LASIK surgery using the LenSx Laser to create the corneal flap prior to excimer laser treatment.

Subjects will be evaluated intraoperatively to assess the ease of lifting the flaps, the stromal bed quality, and the amount of opaque bubble layer. All patients will be followed with routine vision exams for 3 months postoperatively to evaluate changes in visual acuity, manifest refraction, slit lamp examination, and endothelial cell counts.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Budapest, Hungary, 1085
        • Department of Ophthalmology, Semmelweis University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Must have myopia or hyperopia eligible for femtosecond initiated LASIK surgery
  2. Must be over 18 years of age
  3. Must have visual acuity correctable to at least 20/25 in both eyes
  4. If subject is a contact lens wearer, discontinuation of contact lens wear prior to preoperative exam (2 weeks prior for soft contact lenses, 4 weeks prior for rigid gas permeable contact lenses, and 8 weeks prior for hard contact lenses)
  5. Must be willing and able to return for scheduled follow up examinations through 3 months after surgery
  6. Must sign and be given a copy of the written Informed Consent form
  7. Postoperative refractive target is emmetropia

Exclusion Criteria:

  1. Known sensitivity to planned study concomitant medications
  2. Participation in any other ophthalmic drug or device clinical trial during the time of this clinical investigation
  3. Presenting any contraindications to femtosecond initiated LASIK
  4. Corneal thickness values that will result in residual bed less than 280 microns when flap resection and excimer ablation are calculated
  5. Irregular astigmatism, based on Investigator's judgment
  6. Undergoing monovision LASIK
  7. Pregnant, lactating or plan to become pregnant during the course of this study
  8. For bilateral second study eyes only: The surgeon shall not proceed with the second eye until the 1 week exam of the first eye shows no vision threatening complications.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: LASIK Flap Arm
This is a single arm study.
The LenSx laser system is a femtosecond laser that has received 510(k) clearance for anterior capsulotomy during cataract surgery (K082947), laser phacofragmentation during cataract surgery (K094052) and for use in the creation of a single and multi-plane arc cut/incisions in the cornea (K092647).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease of Lifting Flaps
Time Frame: Operative

0 - Unable to lift flap

  1. - Able to lift flap with aid of sharp instrument
  2. - Able to lift flap with difficulty using blunt instrument
  3. - Able to lift flap with moderate resistance using blunt instrument
  4. - Able to lift flap with minimal resistance using blunt instrument
  5. - Able to lift flap without any resistance using blunt instrument (Scale)
Operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stromal Bed Quality
Time Frame: Operative

0 - very rough

1- moderately rough 2 - rough 3 - smooth 4 - moderately smooth 5 - very smooth (Scale)

Operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

March 1, 2013

Study Registration Dates

First Submitted

March 15, 2012

First Submitted That Met QC Criteria

March 16, 2012

First Posted (Estimate)

March 19, 2012

Study Record Updates

Last Update Posted (Estimate)

October 27, 2014

Last Update Submitted That Met QC Criteria

October 23, 2014

Last Verified

October 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CS-004f

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on LenSx Laser

3
Subscribe